DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Garibotto V, Herholz K, Boccardi M. , et al; Geneva Task Force for the Roadmap of Alzheimer's Biomarkers.
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
Neurobiol Aging 2017;
52: 183-195
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.